What health officials know, don't know about Brazil P.1 variant

Minnesota health officials confirmed the first case of the P.1 variant in the U.S.
Publish date:

In the national spotlight for an unwanted reason, Minnesota health officials on Monday confirmed the first U.S. case of the coronavirus strain known as the Brazil P.1 variant. 

Little is known about the variant that has wreaked havoc in Brazil, but there are some early findings from health leaders to suggest some possibilities. 

Here's a list of things health officials believe they know about the P.1 variant. 

  • It was first discovered in Brazil as far back as last July. 
  • It is now confirmed in the Minnesota, Peru, Germany, South Korea and Japan. 
  • Its spike protein mutation helps it better attach to cells, meaning it's likely more transmissible. 
  • It might be capable of reinfecting people who previously had the original SARS-CoV-2 strain. 

Here's a list of things health officials don't know about the P.1 variant: 

  • No evidence at this point to suggest that it is deadlier. 
  • No evidence at this point to suggest that it causes more severe illness. 
  • No hard evidence at this point to say that vaccines won't work on it. 

According to the CDC, "there is evidence to suggest that some of the mutations in the P.1 variant may affect its transmissibility and antigenic profile, which may affect the ability of antibodies generated through a previous natural infection or through vaccination to recognize and neutralize the virus."

It's the point of the P.1 strain potentially reinfecting people, possibly evading antibodies and being more contagious, that are causes for concern. 

Moderna announced Monday that its vaccine is slightly less effective against the South Africa variant known as B.1.351, which has similar mutations to the P.1 variant. Though the vaccine isn't quite as effective against the South Africa strain, it does “remain above levels that are expected to be protective," Moderna said, noting that it's now examining whether a booster dose might be required to tackle the South African strain.

Moderna has not published findings of vaccine efficacy specifically for the P.1 strain. 

STAT News, a leading health reporting medium, reported a recent student estimated that around 75% of of people who live in Manaus, Brazil had been infected with the original SARS-CoV-2 strain by October.

In December and January new cases in the city have exploded, raising concerns that the P.1 strain can evade antibodies from SARS-CoV-2, leading to reinfection of people who would've otherwise had an assumed level of immunity after their first bout with COVID-19.

STAT goes on to say that it's also possible that P.1. might be "so transmissible that it can spread just fine even in communities with 75% protection," though it should be noted that a case of reinfection was confirmed by scientists on Sunday

The reinfection involved a 29-year-old woman from Manaus who experienced mild symptom from SARS-CoV-2 in March and then tested positive again in December, with scientists confirmed the second case to be the P.1 variant.

The P.1 variant has been confirmed in just one person in the United States – the Minnesotan who traveled to Brazil, – while the B.1.1.7 variant, known as the United Kingdom strain, has been confirmed in eight Minnesota patients and has been found in dozens of other U.S. states. Both Moderna and Pfizer have announced that their vaccines work against the B.1.1.7 variant. 

"I worry about the shifting baseline and I worry about the fact that we may see this B.1.1.7 take off in the next several weeks, and if that happens on top of the high level of cases we have now, we're in deep trouble," said Dr. Michael Osterholm, director for the Center for Disease Research and Development at the University of MInnesota, on his podcast las week

"We've gotta monitor very, very carefully this other variant that has been found in South Africa as well as in Brazil in terms of what it means for vaccine protection," Osterholm added. "This is going to be a challenge. We're going to get through it. If we need to, we can make new vaccines, but for the time being this is going to be a challenge." 

The latest forecast from Novak Weather

Next Up

stormking bbq

Black Sheep Pizza's owner, Rapids Brewing opening BBQ brewpub in Minneapolis

The brewpub is a new iteration of Jordan Smith's Texas-inspired StormKing BBQ restaurant.


U.S House passes 'For the People Act' in effort to expand voting rights

The bill now heads to the Senate, where it faces the challenge of the filibuster.

Stephen Weatherly

Vikings to bring back former DE Stephen Weatherly

Weatherly spent last season at the Carolina Panthers.

All Energy Solar Residential Installation

End 'renting' from your utility company and go solar

A solar installation is one of the few home improvements that actually pays for itself.

Mayo clinic

Mayo Clinic makes $727M profits in 2020 despite pandemic

The clinic cited philanthropic gifts, investments and alternative revenue sources.


Walz: New COVID vaccine 'accelerates' state's vaccine rollout timeline

The governor said Wednesday the state will "significantly beat" its goal to vaccinate 70% of people 65 and older by the end of March.

Karl-Anthony Towns

Hornets erupt in 2nd half to blow out Timberwolves

The Timberwolves were outscored 73-46 after halftime.


Authorities investigate fatal Bloomington house fire

One person has been reported dead in the fire.

Minneapolis skyline

New tool helps Minneapolis homeowners disavow racial covenants in deeds

A new free program connects homeowners with the City Attorney's office to complete the process

Kyle Rudolph

Watch: Vikings create tribute video for Kyle Rudolph

Rudolph's 10-year tenure with the Vikings ended when he was released on Tuesday.


coronavirus, SARS-CoV-2

Minnesota confirms America's 1st case of Brazil P.1 COVID strain

The strain was found in a Twin Cities metro resident who recently traveled to Brazil.


Walz: New coronavirus variant 'is probably here' in Minnesota

A new strain has not yet been confirmed in Minnesota.


Osterholm: B117 COVID strain could become major issue in 6-8 weeks

The B117 variant is believed to be more easily transmitted.

covid, coronavirus

MDH: New COVID strain likely broadly circulating in Minnesota

Health officials believe the new strain is broadly circulating in Minnesota.


What Dr. Michael Osterholm says about new coronavirus strains

"What we're seeing right now in England I think is going to be a harbinger of things to come," said Osterholm.

heart monitor, hospital

What health officials have learned about COVID-19 deaths in MN

As of Tuesday, medical records of 146 of 405 hospitalized COVID-19 patients in Minnesota have been evaluated.

covid, coronavirus

Minnesota health leaders discuss new strain of coronavirus

There are differing viewpoints on how much more transmissible the new strain is.


Walz responds to Osterholm's prediction of a variant-driven spike

Osterholm remains confident that the B.1.1.7. variant will cause big problems within 14 weeks.